Epithalon
Epithalon (Epitalon) — Tetrapeptide Ala-Glu-Asp-Gly
Epithalon (also written Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a polypeptide extract of the pineal gland. It has been researched since the 1980s by the St. Petersburg Institute of Biogerontology, primarily for its effects on telomerase activation, pineal gland function, circadian rhythm regulation, and lifespan extension.
Mechanism of Action
Epithalon is the most studied peptide for telomere biology. Research demonstrates it activates telomerase (hTERT — the enzyme that extends telomeres) in human somatic cells, potentially reversing the telomere shortening that accompanies cellular ageing. Telomere lengthening via Epithalon has been confirmed in human cell culture studies.
Epithalon also stimulates the pineal gland to produce melatonin more effectively. Melatonin decline is a hallmark of ageing, and its restoration contributes to improved circadian rhythm regulation, immune function, and antioxidant capacity — multiple pathways relevant to healthy ageing.
Additional mechanisms include inhibition of oncogene expression, reduction of lipid peroxidation, and regulation of cortisol and gonadotropin secretion. Longitudinal human studies from Russia show reduced cancer incidence and cardiovascular mortality in Epithalon-treated elderly cohorts.
Research Evidence
Epithalon has a unique research record — longitudinal human studies (20+ years) conducted primarily in Russia. While not meeting Western RCT standards, these studies provide an unusual depth of long-term human data for a research peptide.
Epithalon Activates Telomerase and Elongates Telomeres in Human Somatic Cells
Epithalon treatment of normal human cells in vitro produced a 33% increase in telomerase activity and measurable telomere elongation after 12 passages, confirming telomere biology effects in human cells.
Peptide Bioregulation in Prevention of Ageing: 25-Year Follow-Up
266 elderly patients receiving annual thymalin + epithalamin courses over 12 years showed 2-fold lower mortality, reduced cardiovascular and cancer incidence, and preserved neuropsychic status versus matched controls.
Typical Research Protocol
Traditional Russian protocol uses 10mg/day × 10 days, repeated twice yearly (spring and autumn). Some researchers use shorter, more frequent cycles (5mg/day × 5–7 days monthly). IV delivery is used in clinical settings.
Safety Profile
Reported Side Effects
- Injection site redness
- Mild fatigue (first few days)
- Vivid dreams (pineal modulation)
Contraindications
- Active malignancy (telomerase activation in cancer cells is theoretical concern)
- Autoimmune conditions (caution)
- Pregnancy (no data)
Common Research Stacks
Frequently Asked Questions
Does Epithalon actually extend lifespan?
In mouse studies, Epithalon produced a 13% increase in median lifespan. In fruitfly studies, lifespan extension of 16% was observed. Human data from Russian longitudinal studies showed significantly reduced mortality in treated elderly cohorts over 6–12 year follow-up periods. The biological plausibility (telomere extension, melatonin restoration) supports the findings, but Western regulatory-standard RCTs are lacking.
What is the difference between Epithalon and Epithalamin?
Epithalamin is a natural polypeptide extract from the pineal gland of cattle used in the original Russian research. Epithalon (Epitalon) is the synthetic tetrapeptide (Ala-Glu-Asp-Gly) designed to replicate the active component of Epithalamin. Epithalon is the form used in most modern research and is more precisely characterised than the complex natural extract.
How is Epithalon administered in practice?
The traditional Russian protocol uses SC injection of 5–10 mg daily for a 10-day course, repeated twice yearly (spring and autumn). Some practitioners use shorter more frequent courses (5mg × 5 days monthly) or IV delivery in clinical settings. Intranasal Epithalon is explored as an alternative, though bioavailability data for that route is limited.
Can Epithalon improve sleep quality?
Yes — Epithalon stimulates melatonin production by the pineal gland, which directly supports circadian rhythm regulation and sleep quality. Vivid dreams during Epithalon courses are commonly reported and are attributed to pineal activation. Research in aged animals showed restoration of melatonin circadian rhythm patterns toward those seen in young animals.
Is Epithalon safe to use if I have cancer?
Epithalon's telomerase-activating mechanism raises theoretical concerns in active malignancy, since cancer cells rely on telomerase to maintain replicative immortality. Most protocols and researchers list active cancer as a contraindication. However, the Russian longevity data showed reduced cancer incidence in treated cohorts, suggesting a complex relationship. This contradiction remains unresolved — avoid use during active cancer treatment until more data is available.
Key Research References
- Khavinson VKh et al. (2003). Epithalon activates telomerase in human somatic cells. Bull Exp Biol Med.
- Anisimov VN et al. (2001). Effect of epithalamin on lifespan and tumour incidence in female mice. Mech Ageing Dev.
Explore more Longevity research compounds
Browse Longevity →